GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Samil Pharmaceutical Co Ltd (XKRX:000520) » Definitions » Gross Margin %

Samil Pharmaceutical Co (XKRX:000520) Gross Margin % : 39.54% (As of Dec. 2023)


View and export this data going back to 1985. Start your Free Trial

What is Samil Pharmaceutical Co Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Samil Pharmaceutical Co's Gross Profit for the three months ended in Dec. 2023 was ₩19,974 Mil. Samil Pharmaceutical Co's Revenue for the three months ended in Dec. 2023 was ₩50,516 Mil. Therefore, Samil Pharmaceutical Co's Gross Margin % for the quarter that ended in Dec. 2023 was 39.54%.


The historical rank and industry rank for Samil Pharmaceutical Co's Gross Margin % or its related term are showing as below:

XKRX:000520' s Gross Margin % Range Over the Past 10 Years
Min: 36.49   Med: 39.17   Max: 44.44
Current: 37.73


During the past 13 years, the highest Gross Margin % of Samil Pharmaceutical Co was 44.44%. The lowest was 36.49%. And the median was 39.17%.

XKRX:000520's Gross Margin % is ranked worse than
66.67% of 987 companies
in the Drug Manufacturers industry
Industry Median: 46.23 vs XKRX:000520: 37.73

Samil Pharmaceutical Co had a gross margin of 39.54% for the quarter that ended in Dec. 2023 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for Samil Pharmaceutical Co was -0.10% per year.


Samil Pharmaceutical Co Gross Margin % Historical Data

The historical data trend for Samil Pharmaceutical Co's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Samil Pharmaceutical Co Gross Margin % Chart

Samil Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 38.58 39.86 36.49 37.56 37.72

Samil Pharmaceutical Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.47 38.20 38.62 34.69 39.54

Competitive Comparison of Samil Pharmaceutical Co's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Samil Pharmaceutical Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Samil Pharmaceutical Co's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Samil Pharmaceutical Co's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Samil Pharmaceutical Co's Gross Margin % falls into.



Samil Pharmaceutical Co Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Samil Pharmaceutical Co's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=74070.8 / 196345.808
=(Revenue - Cost of Goods Sold) / Revenue
=(196345.808 - 122275.013) / 196345.808
=37.72 %

Samil Pharmaceutical Co's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=19974 / 50515.541
=(Revenue - Cost of Goods Sold) / Revenue
=(50515.541 - 30541.579) / 50515.541
=39.54 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Samil Pharmaceutical Co  (XKRX:000520) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Samil Pharmaceutical Co had a gross margin of 39.54% for the quarter that ended in Dec. 2023 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Samil Pharmaceutical Co Gross Margin % Related Terms

Thank you for viewing the detailed overview of Samil Pharmaceutical Co's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Samil Pharmaceutical Co (XKRX:000520) Business Description

Traded in Other Exchanges
N/A
Address
990-1, Bangbae-dong, Seocho-Gu, Seoul, KOR, 137-060
Samil Pharmaceutical Co Ltd is engaged in manufacturing and distribution of pharmaceutical products and medicines in South Korea. Its products portfolio consists of gastrointestinal drugs such as antiulcerants, gastroprokinetic agents, digestive enzymes with nutrients and laxatives.

Samil Pharmaceutical Co (XKRX:000520) Headlines

No Headlines